Intel’s execution is recovering, but the $100.10 stock requires profitable 18A yields and external foundry adoption to justify its asymmetric turnaround upside.
Overview
Intel is a high-risk semiconductor turnaround centered on IDM 2.0: Intel Products houses CCPG and DCAI, while Intel Foundry is being developed as an independent commercial manufacturing and packaging business. The Q2 2026 results demonstrate improved execution, with revenue of $16.13 billion, up 25.4% year over year and $1.80 billion above consensus, while adjusted diluted EPS of $0.42 doubled the $0.21 estimate. Non-GAAP gross margin reached 41.8%, up 12.1 percentage points year over year, and the company delivered its seventh consecutive guidance beat. **The central investment debate is whether 18A and 18A-P achieve profitable volume yields and attract external customers.** The opportunity is substantial because DCAI grew 59%, Foundry grew 31%, and PowerVia may provide a temporary efficiency advantage over TSMC. However, the stock at $100.10 already trades at approximately 84.7x forward FY2026 non-GAAP P/E. Q3 guidance implies $16.3 billion midpoint revenue and $0.38 non-GAAP EPS. The probability-weighted five-year target is $129.72, or 29.59% upside, but the bear case is $33.14 if execution fails.